JB Meigs, CJ O'Donnell, GH Tofler, EJ Benjamin, CS … - Diabetes, 2006 - Am Diabetes Assoc Endothelial dysfunction may precede development of type 2 diabetes. We tested the hypothesis
that elevated levels of hemostatic markers of endothelial dysfunction, plasminogen activator
inhibitor-1 (PAI-1) antigen, and von Willebrand factor (vWF) antigen predicted incident ... Cited by 62 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org A Festa, K Williams, RP Tracy, LE Wagenknecht, SM … - Circulation, 2006 - Am Heart Assoc Methods and Results— After a follow-up of 5.2 years, diabetes developed in 140 (16.6%) of 843
individuals (57% women; mean age [range], 54.7 [40, 69] years) (converters versus
nonconverters). Baseline and follow-up levels of PAI-1 and fibrinogen (demographically ... Cited by 50 - Related articles - All 6 versions
AM Kanaya, W Fyr… - Archives of Internal Medicine, 2006 - Am Med Assoc Methods We analyzed the relationships among adiposity, adipocytokines, glycemia, and incident
diabetes mellitus in 2356 white and black adults aged 70 to 79 years in the Health, Aging, and
Body Composition Study who did not have diabetes at baseline. We measured the levels ... Cited by 39 - Related articles - All 4 versions
R Rossi, E Cioni, A Nuzzo, G Origliani, MG Modena - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—Both postmenopausal state and diabetes are associated with endothelial dysfunction
and are well-known risk factors for atherosclerosis. However, the relationship of
endothelium-dependent vasodilation and diabetes has never been prospectively ... Cited by 31 - Related articles - All 5 versions
JB Meigs, FB Hu, N Rifai, JAE Manson - Jama, 2004 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Endothelial dysfunction occurs in ... Cited by 210 - Related articles - BL Direct - All 6 versions
C Lopes, C Dina, E Durand, P Froguel - Diabetologia, 2003 - Springer Aim/hypothesis. Plasminogen activator inhibitor-1 (PAI-1) is a main regulator of the endogenous
fibrino- lytic system and modulates the thrombosis progression. We analyzed genetic contributions
of PAI-1 mutations to the metabolic syndrome and to its complications. Methods. PAI-1 ... Cited by 35 - Related articles - BL Direct - All 3 versions
[CITATION] Comment on: The common-675 4G/5G polymorphism in the plasminogen activator …
- ►ahajournals.org DL Crandall, EM Quinet, S El Ayachi, AL … - … , and vascular biology, 2006 - Am Heart Assoc Methods and Results— In human preadipocyte cultures, PAI-039 inhibited both basal and
glucose-stimulated increases in active PAI-1 antigen, yet had no effect on PAI-1 mRNA, suggesting
a direct inactivation of PAI-1. Differentiation of human preadipocytes to adipocytes was ... Cited by 27 - Related articles - All 9 versions
- ►prsjournal.net C Zoccali, E Puntorieri - Journal of Hypertension, 2008 - journals.lww.com From a clinical and epidemiologic point of view, diabetes is an undisputable, major risk factor
for cardiovascular complications. The magnitude of the diabetes mortality link – is of the same
order as that of a coronary event (a doubling in the risk of death), and for this reason, ... Related articles - All 6 versions
